A Fixed-Dose Combination of Bisoprolol and Amlodipine for Hypertension: A Potential Benefit to Selected Patients
Author:
Affiliation:
1. Division of Clinical Decision Making; Department of Medicine; Tufts Medical Center; Boston MA USA
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Reference31 articles.
1. Global burden of hypertension: analysis of worldwide data;Kearney;Lancet,2005
2. Results in patients with diastolic blood pressure averaging 115-129 mm Hg;Veterans Administration Cooperative Study Group on AntihypertensiveAgents: Effects of treatment on morbidity and mortality in hypertension: I;JAMA,1967
3. Combination therapy in hypertension;Gradman;J Am Soc Hypertens,2010
4. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;Blood Press,2013
5. Clinical practice guidelines for the management of hypertension in the community;Weber;J Clin Hypertens,2014
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe;Current Medical Research and Opinion;2024-03-26
2. Comparison of Pharmacokinetics and Bioavailability of Fixed‐Dose Combination Tablet and Monotherapy Combination of Allisartan Isoproxil and Indapamide Sustained‐Release in Healthy Chinese Volunteers;Clinical Pharmacology in Drug Development;2023-09-10
3. Symmetric and asymmetric separations of bisoprolol enantiomers: Optimization and application;Process Biochemistry;2019-11
4. Bioequivalence and Pharmacokinetics of Bisoprolol–Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects;Clinical Drug Investigation;2018-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3